SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125567
Filing Date
2024-11-12
Accepted
2024-11-12 16:39:21
Documents
79
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sybx-20240930.htm   iXBRL 10-Q 2451060
2 EX-10.3 sybx-ex10_7.htm EX-10.7 73580
3 EX-10.4 sybx-ex10_8.htm EX-10.8 19828
4 EX-10.5 sybx-ex10_9.htm EX-10.9 72772
5 EX-10.6 sybx-ex10_10.htm EX-10.10 14206
6 EX-31.1 sybx-ex31_1.htm EX-31.1 14481
7 EX-31.2 sybx-ex31_2.htm EX-31.2 14343
8 EX-32.1 sybx-ex32_1.htm EX-32.1 7425
9 EX-32.2 sybx-ex32_2.htm EX-32.2 7309
10 GRAPHIC img121614487_0.jpg GRAPHIC 70319
11 GRAPHIC img144758511_0.jpg GRAPHIC 5382
12 GRAPHIC img260685902_0.jpg GRAPHIC 5382
  Complete submission text file 0000950170-24-125567.txt   9557196

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sybx-20240930.xsd EX-101.SCH 1139050
81 EXTRACTED XBRL INSTANCE DOCUMENT sybx-20240930_htm.xml XML 1673482
Mailing Address PO BOX 30 WINCHESTER MA 01890
Business Address PO BOX 30 WINCHESTER MA 01890 617-659-2802
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 241449158
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)